Sarkar B, Napolitano L M
Division of Acute Care Surgery, Department of Surgery, University of Michigan, and University of Michigan Health System, University Hospital, Ann Arbor, MI 48109-0033, USA.
Minerva Chir. 2010 Jun;65(3):347-62.
Necrotizing soft tissue infections (NSTIs) are aggressive severe soft tissue infection that cause rapid and widespread infection and necrosis of the skin and soft tissues and are highly lethal. NSTIs include necrotizing cellulitis, adipositis, fasciitis and myositis/myonecrosis and have significant potential for extensive soft tissue and limb loss. Early diagnosis and treatment of NSTIs remains the cornerstone of therapy. Timely aggressive surgical debridement and early appropriate antibiotic treatment are required for a successful outcome and clinical cure. Mortality rate has decreased from 25-50% in past years, to 10-16% in recent years with aggressive surgical and medical management. Additional innovative strategies for the treatment of NSTIs, including intravenous immuno-globulin G (IVIG), hyperbaric oxygen, and vacuum-assisted closure, do not yet have definitive evidence of efficacy, but may be considered in patients at high risk of death. A comprehensive knowledge of the pathophysiology, diagnostic features, causative microbial pathogens, and treatment strategies (including surgical debridement and antimicrobial therapy) is required for successful management of NSTIs.
坏死性软组织感染(NSTIs)是一种侵袭性严重软组织感染,可导致皮肤和软组织迅速广泛感染及坏死,且致死率很高。NSTIs包括坏死性蜂窝织炎、脂肪炎、筋膜炎和肌炎/肌坏死,有导致广泛软组织缺损和肢体缺失的巨大可能性。NSTIs的早期诊断和治疗仍然是治疗的基石。为了取得成功的治疗结果和临床治愈,需要及时进行积极的手术清创和早期适当的抗生素治疗。死亡率已从过去的25%-50%降至近年来积极手术和药物治疗后的10%-16%。治疗NSTIs的其他创新策略,包括静脉注射免疫球蛋白G(IVIG)、高压氧和负压封闭引流,尚未有确切的疗效证据,但可考虑用于死亡风险高的患者。成功管理NSTIs需要全面了解其病理生理学、诊断特征、致病微生物病原体以及治疗策略(包括手术清创和抗菌治疗)。